AUPH.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
symbol | last | change | %chng | name | mcap | sector | wiki | |
---|---|---|---|---|---|---|---|---|
AUPH | US | Aurinia Pharmaceuticals Inc | 1.286B | Healthcare |
Stock industry analysis for AUPH (Aurinia Pharmaceuticals)
Compares a stock with a basket of similar stocks. This is useful to determine why a share price moves. In some cases it is because the company has great leadership and brilliant products in which case the company news becomes important. In other cases it is because they are in a good industry in which case the industry news is most important.
AUPH (US) Aurinia Pharmaceuticals vs g.trial clinical
Daily share price volatility analysis
- the company and the industry contribute to the movement of the share price
- correlation of stock with industry 78.61%
- beta of stock with industry 1.02
- volatility of g.trial clinical 81.62%
- volatility of stock (AUPH) 105.92%
- volatility of industry component: 83.27%
- volatility of stock specific component: 65.47%
- 61.81% of the price volatility is due to the stock and not the industry, which is 38.2% of the variance
- 78.61% of the price volatility is due to the industry not the stock, which is 61.8% of the variance
Monthly price volatility analysis
- the company and the industry contribute to the movement of the share price
- correlation of stock with industry 75.83%
- beta of stock with industry 1.03
- volatility of g.trial clinical 80.94%
- volatility of stock (AUPH) 109.91%
- volatility of industry component: 83.35%
- volatility of stock specific component: 71.65%
- 65.19% of the price volatility is due to the stock and not the industry, which is 42.5% of the variance
- 75.83% of the price volatility is due to the industry not the stock, which is 57.5% of the variance
Stock component chart
This chart shows the stock and compares it with an index made up of similar stocks. This helps identify whether it is the company or the industry which is driving the share price.
Red and green candlesticks show AUPH, the blue line is the comparisonstock specific component
The chart shows in blue is just the company component of the price after removing the industry component. This is helpful to see if there is buying or selling in the specific stock that may last a few days. The component chart is designed to have the same final price as the company for easy comparison. The green line is a 5 day moving average
symbols in g.trial clinical
Crispr Therapeutics AG | CRSP | US | Healthcare | 36.4419 | 4327M | wiki |
Reata Pharmaceuticals Inc | RETA | US | Healthcare | 24.5025 | 1791M | wiki |
argenx NV ADR | ARGX | US | Healthcare | 30.5813 | 20576M | |
Apellis Pharmaceuticals Inc | APLS | US | Healthcare | 55.6489 | 6056M | |
Ascendis Pharma AS | ASND | US | Healthcare | 30.3054 | 6621M | |
Viking Therapeutics Inc | VKTX | US | Healthcare | 45.1808 | 698M | |
Iovance Biotherapeutics Inc | IOVA | US | Healthcare | 23.2408 | 1260M | wiki |
Intellia Therapeutics Inc | NTLA | US | Healthcare | 34.3129 | 3727M | wiki |
Myovant Sciences Ltd | MYOV | US | Healthcare | 29.3398 | 2614M | |
Xenon Pharmaceuticals Inc | XENE | US | Healthcare | 21.9326 | 2451M | |
Biohaven Pharmaceutical Holding Co Ltd | BHVN | US | 46.8683 | 944M | ||
BeiGene Ltd | BGNE | US | Healthcare | 24.8804 | 27267M | wiki |
Rhythm Pharmaceuticals Inc | RYTM | US | Healthcare | 50.9962 | 1613M | |
Crinetics Pharmaceuticals Inc | CRNX | US | Healthcare | 35.2204 | 1072M | |
Aurinia Pharmaceuticals Inc | AUPH | US | Healthcare | 22.7086 | 1286M | |
Editas Medicine Inc | EDIT | US | Healthcare | 34.4269 | 809M | wiki |
Syndax Pharmaceuticals Inc | SNDX | US | Healthcare | 29.9689 | 1904M | |
Replimune Group Inc | REPL | US | Healthcare | 38.8043 | 1559M | |
Scholar Rock Holding Corp | SRRK | US | Healthcare | 38.7539 | 644M | |
Denali Therapeutics Inc | DNLI | US | Healthcare | 65.694 | 4305M | |
MorphoSys AG ADR | MOR | US | Healthcare | 31.0713 | 685M | wiki |
Protagonist Therapeutics Inc | PTGX | US | Healthcare | 25.8701 | 705M | |
Merus BV | MRUS | US | Healthcare | 22.6897 | 733M | |
Arcus Biosciences Inc | RCUS | US | Healthcare | 31.7188 | 1485M | |
Deciphera Pharmaceuticals LLC | DCPH | US | Healthcare | 50.1382 | 1288M | |
Kiniksa Pharmaceuticals Ltd | KNSA | US | Healthcare | 24.3077 | 980M | |
Allogene Therapeutics Inc | ALLO | US | Healthcare | 38.0183 | 1122M | |
Kura Oncology Inc | KURA | US | Healthcare | 41.3642 | 914M | |
G1 Therapeutics Inc | GTHX | US | Healthcare | 56.9082 | 400M | wiki |
Mersana Therapeutics Inc | MRSN | US | Healthcare | 31.9748 | 700M | |
UroGen Pharma Ltd | URGN | US | Healthcare | 64.7271 | 214M | |
AnaptysBio Inc | ANAB | US | Healthcare | 48.3541 | 733M | |
Jounce Therapeutics Inc | JNCE | US | Healthcare | 25.9098 | 63M | |
Fate Therapeutics Inc | FATE | US | Healthcare | 35.8753 | 668M | |
Allakos Inc | ALLK | US | Healthcare | 65.2213 | 614M | |
Aeglea Bio Therapeutics Inc | AGLE | US | Healthcare | 37.5386 | 31M | |
X4 Pharmaceuticals Inc | XFOR | US | Healthcare | 20.7317 | 126M | |
Syros Pharmaceuticals Inc | SYRS | US | Healthcare | 36.9493 | 102M | |
Codexis Inc | CDXS | US | Healthcare | 20.1967 | 424M | wiki |
Magenta Therapeutics Inc | MGTA | US | Healthcare | 34.2297 | 52M | |
MeiraGTx Holdings PLC | MGTX | US | Healthcare | 32.6751 | 394M | |
Verrica Pharmaceuticals Inc | VRCA | US | Healthcare | 28.7698 | 215M | |
AVROBIO Inc | AVRO | US | Healthcare | 38.8009 | 41M | |
Spero Therapeutics Inc | SPRO | US | Healthcare | 28.324 | 99M | |
Homology Medicines Inc | FIXX | US | Healthcare | 43.3588 | 97M | |
Odonate Therapeutics Inc | ODT | US | Pharmaceuticals | 35.9218 | 43M | |
Tricida Inc | TCDA | US | Healthcare | 45.4183 | 6M | |
Rubius Therapeutics Inc | RUBY | US | Healthcare | 34.1062 | 25M | |
Athenex Inc | ATNX | US | Healthcare | 44.748 | 30M | |
Akcea Therapeutics, Inc | AKCA | US | 60.9863 | |||
Principia Biopharma Inc | PRNB | US | 32.4072 |